189 related articles for article (PubMed ID: 16817795)
21. Heparin-induced extracorporeal low-density lipoprotein precipitation.
Mellwig KP
Ther Apher Dial; 2003 Jun; 7(3):365-9. PubMed ID: 12924614
[TBL] [Abstract][Full Text] [Related]
22. [Effects of LDL-apheresis--more than reduction of cholesterol?].
Schettler V; Wieland E
Dtsch Med Wochenschr; 2007 Mar; 132(11):575-8. PubMed ID: 17342636
[TBL] [Abstract][Full Text] [Related]
23. [Myocardial perfusion under H.E.L.P. -apheresis. Objectification by PET].
Mellwig KP; Baller D; Schmidt HK; V Buuren F; Wielepp JP; Burchert W; Horstkotte D
Z Kardiol; 2003; 92(Suppl 3):III30-7. PubMed ID: 14663599
[TBL] [Abstract][Full Text] [Related]
24. Fibrinogen/LDL apheresis is a promising rescue therapy for sudden sensorineural hearing loss.
Canis M; Heigl F; Suckfuell M
Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):36-40. PubMed ID: 22528132
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of low-density lipoprotein apheresis in patients with peripheral arterial occlusive disease undergoing hemodialysis treatment.
Morimoto S; Yano Y; Maki K; Sawada K; Iwasaka T
Am J Nephrol; 2007; 27(6):643-8. PubMed ID: 17878713
[TBL] [Abstract][Full Text] [Related]
26. Lipidfiltration--safe and effective methodology to perform lipid-apheresis.
Klingel R; Mausfeld P; Fassbender C; Goehlen B
Transfus Apher Sci; 2004 Jun; 30(3):245-54. PubMed ID: 15172630
[TBL] [Abstract][Full Text] [Related]
27. Acute effect of rheopheresis on peripheral endothelial dysfunction in patients suffering from sudden hearing loss.
Balletshofer BM; Stock J; Rittig K; Lehn-Stefan A; Braun N; Burkart F; Plontke S; Klingel R; Häring HU
Ther Apher Dial; 2005 Oct; 9(5):385-90. PubMed ID: 16202012
[TBL] [Abstract][Full Text] [Related]
28. Clinical utility of LDL-apheresis in the treatment of sudden hearing loss: a prospective, randomized study.
Suckfüll M; Thiery J; Schorn K; Kastenbauer E; Seidel D
Acta Otolaryngol; 1999; 119(7):763-6. PubMed ID: 10687932
[TBL] [Abstract][Full Text] [Related]
29. Low-density lipoprotein apheresis in children with familial hypercholesterolemia: follow-up to 21 years.
Palcoux JB; Atassi-Dumont M; Lefevre P; Hequet O; Schlienger JL; Brignon P; Roussel B
Ther Apher Dial; 2008 Jun; 12(3):195-201. PubMed ID: 18503695
[TBL] [Abstract][Full Text] [Related]
30. LDL-apheresis accelerates the recovery of nonarteritic acute anterior ischemic optic neuropathy.
Ramunni A; Giancipoli G; Guerriero S; Lapenna L; Saracino A; Saliani MT; Capurso A; Sborgia C; Coratelli P
Ther Apher Dial; 2005 Feb; 9(1):53-8. PubMed ID: 15828907
[TBL] [Abstract][Full Text] [Related]
31. Circulating oxidized LDL is associated with increased levels of cell-adhesion molecules in clinically healthy 58-year old men (AIR study).
Hulthe J; Fagerberg B
Med Sci Monit; 2002 Mar; 8(3):CR148-52. PubMed ID: 11887026
[TBL] [Abstract][Full Text] [Related]
32. Effects of selective LDL apheresis on plasma concentrations of ICAM-1, VCAM-1 and P-selectin in diabetic patients with arteriosclerosis obliterans and receiving maintenance hemodialysis.
Utsumi K; Kawabe M; Hirama A; Ueda K; Kamada Y; Arii K; Komaba Y; Katsura K; Iino Y; Katayama Y
Clin Chim Acta; 2007 Feb; 377(1-2):198-200. PubMed ID: 17126824
[TBL] [Abstract][Full Text] [Related]
33. Apheresis for idiopathic sudden hearing loss: reviewing the evidence.
Finger RP; Gostian AO
J Clin Apher; 2006 Dec; 21(4):241-5. PubMed ID: 16532475
[TBL] [Abstract][Full Text] [Related]
34. Role of low-density lipoprotein apheresis.
Ziajka P
Am J Cardiol; 2005 Aug; 96(4A):67E-69E. PubMed ID: 16098847
[TBL] [Abstract][Full Text] [Related]
35. Changes in myocardial vasoreactivity after drastic reduction of plasma fibrinogen and cholesterol: a clinical study in long-term heart transplant survivors using positron emission tomography.
Jaeger BR; Bengel FM; Odaka K; Uberfuhr P; Labarrere CA; Bengsch S; Engelschalk C; Kreuzer E; Reichart B; Schwaiger M; Seidel D
J Heart Lung Transplant; 2005 Dec; 24(12):2022-30. PubMed ID: 16364844
[TBL] [Abstract][Full Text] [Related]
36. The effect of low-density lipoprotein apheresis on ocular microcirculation in patients with hypercholesterolaemia: a pilot study.
Terai N; Julius U; Haustein M; Spoerl E; Pillunat LE
Br J Ophthalmol; 2011 Mar; 95(3):401-4. PubMed ID: 20530658
[TBL] [Abstract][Full Text] [Related]
37. Evidence for maximal treatment of atherosclerosis: drastic reduction of cholesterol and fibrinogen restores vascular homeostasis.
Jaeger BR
Ther Apher; 2001 Jun; 5(3):207-11. PubMed ID: 11467757
[TBL] [Abstract][Full Text] [Related]
38. Extracorporal low-density lipoprotein elimination by immunoadsorption.
Ritter MM; Parhofer KG
Ther Apher Dial; 2003 Jun; 7(3):370-2. PubMed ID: 12924615
[TBL] [Abstract][Full Text] [Related]
39. What's going on in LDL apheresis.
Onofrillo D; Accorsi P
Transfus Apher Sci; 2007 Dec; 37(3):213-21. PubMed ID: 18054286
[No Abstract] [Full Text] [Related]
40. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
Tsuchida H; Shigematsu H; Ishimaru S; Iwai T; Akaba N; Umezu S
Int Angiol; 2006 Sep; 25(3):287-92. PubMed ID: 16878078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
